Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [11C]methionine PET.

Journal of neuro-oncology - 1 Dec 2023

Chen Qiang, Wang Kai, Ren Xiaohui, Zhao Xiaobin, Chen Qian, Fan Di, Zhang Shu, Li Xiaotong, Ai Lin

Abstract excerpt

PURPOSE: This study aimed to assess the ability of [11C]methionine (MET) PET in distinguishing between tumor progression (TP) and treatment-related changes (TRCs) among different types of adult-type diffuse gliomas according to the 2021 World Health Organization classification and predict overall survival (OS). METHODS: We retrospectively selected 113 patients with adult-type diffuse gliomas with suspected TP who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Methionine

Share to Mutation

Share to Oligodendroglioma

Share to Positron-Emission Tomography

Source

Identifiers

PMID: 38095773
DOI: 10.1007/s11060-023-04529-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [11C]methionine PET.PMID 38095773Read ↗

Imaging-Based Versus Pathologic Survival Stratifications of Diffuse Glioma According to the 2021 WHO Classification System.Semantic proximity Read ↗

Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study.Semantic proximity Read ↗

The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas.Semantic proximity Read ↗

Pre-operative dual-time-point [18F]FET PET differentiates CDKN2A/B loss and PIK3CA mutation status in adult-type diffuse glioma: a single-center prospective study.Semantic proximity Read ↗

Diffuse glioma, not otherwise specified: imaging-based risk stratification achieves histomolecular-level prognostication.Semantic proximity Read ↗

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.Semantic proximity Read ↗

Classification of adult-type diffuse gliomas: Impact of the World Health Organization 2021 update.Semantic proximity Read ↗

Adult type diffuse gliomas in the new 2021 WHO Classification.Semantic proximity Read ↗

Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Semantic proximity Read ↗

National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.Semantic proximity Read ↗

Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis.Semantic proximity Read ↗

World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.